Show results for
Refine by
Cancer Detection Equipment & Supplies In Uganda
52 equipment items found
by:Acuamark Diagnostics based inNew York, NEW YORK (USA)
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the next two decades, causing deaths to rise to 13M per year (worldwide). Annually, the worldwide economic impact of ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
Manufactured by:VIDAR Systems Corporation based inHerndon, VIRGINIA (USA)
CAD systems incorporate advanced pattern recognition and image analysis, requiring a film digitizer that meets the highest standards of image quality and reliability. These advanced systems enable radiologists to improve their ability to detect early stage cancers in an efficient manner. The CAD PRO Advantage is an ideal fit for mammography facilities ...
Manufactured by:Hybribio based inKowloon Bay, HONG KONG
The Stool DNA Methylation Real-time PCR Kit serves as a diagnostic tool for individuals at high risk of colorectal cancer, facilitating in vitro qualitative detection of methylated SDC2 and TFPI2 genes within intestinal exfoliated cells. Designed for efficacy and user-friendliness, this kit enables easy operation while maintaining a short processing time without ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor and then have 1-4 follow-up visits ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
BC Sera Dx Immunoassay test panel for detection of the presence of breast cancer in women. In the development pipeline are an Ovarian, OV Sera Dx, and Lung, LG Sera Dx, cancer detection test ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with ...
by:GE HealthCare based inChicago, ILLINOIS (USA)
The Invenia ABUS 2.0 is designed as an FDA-approved ultrasound supplemental screening technology, aiming to improve cancer detection in women with dense breast tissue. It offers a 35.7% increase in detection over traditional mammography, thanks to its superior image quality and advanced interpretation tools. The system integrates AI assistance to ...
by:Ezra based inGeorgetown, TEXAS (USA)
Ezra offers advanced MRI-based full-body scans aimed at early cancer detection. The service employs 3 Tesla (3T) MRI technology, known for its higher-resolution imaging and superior signal-to-noise ratio, alongside 1.5 Tesla (1.5T) MRI for broader accessibility. These scans are designed to identify potential early-stage cancers, significantly ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
MHI-148 is a near-infrared heptamethine cyanine dye with tumor-targeting properties for cancer detection, diagnosis and research. MHI-148 is immediately taken up and accumulated by lysosomes and mitochondria of tumor cells, but not in lysosomes and mitochondria of normal ...
Manufactured by:Amadix based inValladolid, SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal Cancer (CRC) and advanced ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique companies using safe therapeutic agents for diagnostic indication. As a non-invasive cost effective red alert tool, it is ...
Manufactured by:Xpedite Diagnostics based inHallbergmoos, GERMANY
While the kit is intended for research use only, its precision and efficiency improve the workflow of laboratories engaged in cancer detection, prenatal screening like NIPT, and pathogen ...
Manufactured by:Amadix based inValladolid, SPAIN
PancreaDix is an innovative, non-invasive signature in blood for: Confirming a Pancreatic cancer diagnosis. Detecting pre-malignant lesions that will evolve to cancer. Performing a differential diagnosis between Pancreatic cancer and other pathologies such as chronic pancreatitis or neuroendocrine tumors. ...
Manufactured by:Imaging Diagnostic Systems, Inc. (IDSI) based inOrlando, FLORIDA (USA)
Computed Tomography Laser Mammography (CTLM) is an innovative imaging method focused on visualizing blood distribution within the breast, helpful for identifying breast abnormalities. This technology offers potential advantages in detecting angiogenesis due to increased blood flow in newly forming tumors, which might be overlooked by routine mammography. Additionally, CTLM excels ...
Manufactured by:Universal Diagnostics SL based inSeville, SPAIN
We are developing Signal-X, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ has the exclusive worldwide license for SubB2M - an engineered protein that binds to a unique sugar molecule called Neu5Gc which is only present in human cancers. In initial clinical studies, SubB2M has detected cancers with 100% sensitivity and specificity for mid to late-stage cancers, and >95% specificity and 100% ...
Manufactured by:Virasoft Inc. based inSarıyer, TURKEY
In reporting of breast cancer pathology, mitosis detection and counting of mitotic cells are important factors that affect the tumor grade and the treatment of the patient. Mitotic cell counting requires standardization to a fixed field area. The total number of mitoses per 10 HPF is recorded. Normally, the count is performed manually by pathologists, but ...
Manufactured by:Metaltronica S.p.A. based inPomezia (Rm), ITALY
The Helianthus Series embraces three different full-field digital flat-panel mammography systems that can perform both screening and 2D or 3D diagnostics. All the mammography equipments benefit from state-of-the-art techniques to detect breast cancer, including dual energy (contrast-enhanced mammography). ...